There are currently no generic versions of Effient (prasugrel). The first patent for the drug expires in April 2017, and it is possible that a generic version may become available after that date. Even though prasugrel is the active ingredient in Effient, it is not the same as a generic version of the drug.
Effient® (prasugrel hydrochloride) is a prescription antiplatelet medication used to prevent strokes, heart attacks, and cardiovascular-related deaths (due to heart attacks or strokes) in people who have had an angioplasty procedure to treat a blocked coronary artery after experiencing a heart attack or heart-related chest pains.
Effient is manufactured by Eli Lilly and Company, and is marketed by Daiichi Sankyo, Inc., and Eli Lilly and Company. No generic versions of Effient are available at this time.
The first patent for Effient is currently set to expire in April 2017. This is the earliest predictable date that a generic version of Effient could become available.
However, other circumstances could come up to extend or shorten this exclusivity period. This could include such things as lawsuits or other patents for specific Effient uses. It is usually quite difficult to predict exactly when a generic version of any medication may become available.
No -- prasugrel is the active ingredient in Effient, but is not a generic version of it. What can be confusing is that oftentimes, the active ingredient of any drug is referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.